These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16533788

  • 1. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models.
    Schluep T, Hwang J, Cheng J, Heidel JD, Bartlett DW, Hollister B, Davis ME.
    Clin Cancer Res; 2006 Mar 01; 12(5):1606-14. PubMed ID: 16533788
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
    Schluep T, Cheng J, Khin KT, Davis ME.
    Cancer Chemother Pharmacol; 2006 May 01; 57(5):654-62. PubMed ID: 16133526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S, McGuire JJ, Rustum YM.
    Clin Cancer Res; 1999 Jul 01; 5(7):1925-34. PubMed ID: 10430100
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
    Mach CM, Mathew L, Mosley SA, Kurzrock R, Smith JA.
    Anticancer Res; 2009 Jun 01; 29(6):1895-9. PubMed ID: 19528445
    [Abstract] [Full Text] [Related]

  • 7. Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin.
    De Cesare M, Pratesi G, Perego P, Carenini N, Tinelli S, Merlini L, Penco S, Pisano C, Bucci F, Vesci L, Pace S, Capocasa F, Carminati P, Zunino F.
    Cancer Res; 2001 Oct 01; 61(19):7189-95. PubMed ID: 11585754
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 9. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA.
    Clin Cancer Res; 2001 May 01; 7(5):1429-37. PubMed ID: 11350914
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH, Akhter J, Wang L, Lu Y, Morris DL.
    Cancer Chemother Pharmacol; 2005 May 01; 55(5):425-32. PubMed ID: 15565325
    [Abstract] [Full Text] [Related]

  • 11. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ, Tian H, Joseph IB, Menon K, Frost D.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):725-32. PubMed ID: 16967299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Zou Y, Fu H, Ghosh S, Farquhar D, Klostergaard J.
    Clin Cancer Res; 2004 Nov 01; 10(21):7382-91. PubMed ID: 15534115
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models.
    Mewani RR, Tang W, Rahman A, Dritschilo A, Ahmad I, Kasid UN, Gokhale PC.
    Int J Oncol; 2004 May 01; 24(5):1181-8. PubMed ID: 15067340
    [Abstract] [Full Text] [Related]

  • 18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 01; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 19. The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pH.
    Flowers JL, Hoffman RM, Driscoll TA, Wall ME, Wani MC, Manikumar G, Friedman HS, Dewhirst M, Colvin OM, Adams DJ.
    Cancer Chemother Pharmacol; 2003 Sep 01; 52(3):253-61. PubMed ID: 12783198
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts.
    Pantazis P, Kozielski AJ, Vardeman DM, Petry ER, Giovanella BC.
    Oncol Res; 1993 Sep 01; 5(8):273-81. PubMed ID: 8012059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.